X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pseudoprogression (530) 530
index medicus (322) 322
humans (265) 265
oncology (234) 234
glioblastoma (201) 201
male (174) 174
female (173) 173
clinical neurology (170) 170
middle aged (152) 152
radiotherapy (149) 149
magnetic resonance imaging (145) 145
adult (124) 124
radiology, nuclear medicine & medical imaging (123) 123
aged (122) 122
disease progression (120) 120
temozolomide (117) 117
brain neoplasms - pathology (113) 113
gliomas (107) 107
radiation necrosis (98) 98
high-grade gliomas (92) 92
chemotherapy (91) 91
glioma (88) 88
immunotherapy (88) 88
medicine & public health (88) 88
brain neoplasms - therapy (82) 82
glioblastoma multiforme (81) 81
survival (75) 75
cancer (74) 74
tumors (72) 72
neurology (69) 69
radiation (69) 69
surgery (69) 69
glioblastoma - pathology (65) 65
malignant glioma (65) 65
patients (65) 65
treatment outcome (65) 65
brain tumors (64) 64
concomitant (64) 64
progression (63) 63
retrospective studies (61) 61
brain neoplasms - diagnostic imaging (60) 60
care and treatment (60) 60
development and progression (60) 60
malignant gliomas (59) 59
prognosis (59) 59
brain (58) 58
therapy (56) 56
diagnosis (55) 55
glioblastoma - therapy (54) 54
neuroimaging (54) 54
brain neoplasms - radiotherapy (53) 53
positron-emission-tomography (53) 53
radiation therapy (53) 53
magnetic resonance imaging - methods (52) 52
young adult (52) 52
necrosis (49) 49
radiation-therapy (49) 49
bevacizumab (48) 48
mri (48) 48
perfusion (47) 47
pseudoresponse (47) 47
brain neoplasms - drug therapy (46) 46
dacarbazine - analogs & derivatives (46) 46
brain neoplasms - mortality (43) 43
brain-tumors (43) 43
response assessment (42) 42
article (41) 41
nivolumab (41) 41
aged, 80 and over (40) 40
glioma - pathology (40) 40
metastasis (39) 39
adjuvant temozolomide (38) 38
differentiation (38) 38
neurosciences (38) 38
recurrence (37) 37
chemoradiotherapy (35) 35
newly-diagnosed glioblastoma (35) 35
brain neoplasms - diagnosis (34) 34
criteria (34) 34
cerebral blood-volume (33) 33
glioblastoma - mortality (33) 33
tumor progression (33) 33
follow-up studies (32) 32
high-grade glioma (32) 32
neurosurgery (32) 32
nuclear magnetic resonance--nmr (32) 32
adolescent (31) 31
brain neoplasms - surgery (31) 31
brain-tumor (31) 31
pseudo-progression (31) 31
neoplasm recurrence, local - pathology (30) 30
survival rate (30) 30
dacarbazine - therapeutic use (29) 29
diffusion (29) 29
glioblastoma - drug therapy (29) 29
glioblastoma-multiforme (29) 29
radiology (29) 29
recurrent glioblastoma (29) 29
analysis (28) 28
combined modality therapy (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (507) 507
French (11) 11
German (6) 6
Spanish (5) 5
Russian (2) 2
Turkish (2) 2
Chinese (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Frontiers in Neurology, ISSN 1664-2295, 2015, Volume 6
Glioblastoma, the most common malignant primary brain tumor in adults is a devastating diagnosis with an average survival of 14-16 months using the current... 
Imaging techniques | Pseudoprogression | Antiangiogenic therapy | Pseudoresponse | Immunotherapy | Glioblastoma | pseudoprogression | antiangiogenic therapy | imaging techniques | pseudoresponse
Journal Article
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, ISSN 0167-8140, 08/2019
Pseudoprogression (PsP) following radiation therapy (RT) for low grade glioma (LGG, WHO grade I and II), including both photon-based intensity-modulated RT... 
Journal Article
Neurosurgery, ISSN 0148-396X, 01/2019, Volume 84, Issue 1, pp. 123 - 131
Abstract BACKGROUND The optimal observation interval after the radiosurgical treatment of a sporadic vestibular schwannoma, prior to salvage intervention, is... 
Gamma Knife | Pseudoprogression | Radiosurgery | Vestibular schwannoma | SURGERY | MANAGEMENT | RESECTION | EXPANSION | CLINICAL NEUROLOGY
Journal Article
Journal of Clinical Medicine, ISSN 2077-0383, 11/2019, Volume 8, Issue 11, p. 2007
Evaluating changes induced by immunotherapies (IT) on conventional magnetic resonance imaging (MRI) is difficult because those treatments may produce... 
pseudoprogression | dwi-mri | glioblastoma | dsc-mri | immunotherapy
Journal Article
AMERICAN JOURNAL OF ROENTGENOLOGY, ISSN 0361-803X, 06/2019, Volume 212, Issue 6, pp. 1177 - 1181
OBJECTIVE. The purpose of this study is to assess the frequency of atypical response patterns in oncology patients treated with the programmed cell death... 
pseudoprogression | CRITERIA | nivolumab | immunotherapy | GUIDELINES | IMMUNE-RELATED RESPONSE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | atypical response
Journal Article
by Just, N
British Journal of Cancer, ISSN 0007-0920, 12/2014, Volume 111, Issue 12, pp. 2205 - 2213
Journal Article
Medicine (United States), ISSN 0025-7974, 03/2017, Volume 96, Issue 11
Journal Article
Immunotherapy, 07/2019
Pseudoprogression is a unique, uncommon phenomenon that often hints at good prognosis. To date, there has been no report of complete remission after... 
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 10/2019, Volume 30, Issue 9, pp. 953 - 958
In the past decade, tumour flare reaction (TFR) was considered as a new side effect associated with immunomodulatory agents (IMiDs) and as a condition of... 
pseudoprogression | haematological malignancies | cancer | Clinical Reports | tumour flare reaction | immunotherapy
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 03/2015, Volume 42, Issue 3, pp. 386 - 396
Ipilimumab is a newly approved immunotherapeutic agent that has been shown to provide a survival benefit in patients with metastatic melanoma. F-18-FDG PET/CT... 
EORTC criteria | CRITERIA | SURVIVAL | Metastatic melanoma | RECIST | F-18-FDG PET/CT | Ipilimumab | GUIDELINES | DACARBAZINE | PSEUDOPROGRESSION | POSITRON-EMISSION-TOMOGRAPHY | IMMUNE THERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Neurosurgery, ISSN 0148-396X, 05/2019, Volume 84, Issue 5, pp. 1133 - 1137
Abstract BACKGROUND Glioblastoma (GBM) is the most common malignant brain tumor in adult patients. Tumor recurrence commonly occurs around the resection... 
MALIGNANT GLIOMA | SURVIVAL | PSEUDOPROGRESSION | Stereotactic radiosurgery | RESECTION | Surgery | Glioblastoma | RESPONSE ASSESSMENT | INTRAOPERATIVE RADIOTHERAPY | MULTIFORME | CLINICAL NEUROLOGY | TEMOZOLOMIDE
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2019, Volume 25, Issue 2, pp. 552 - 561
Purpose: To quantify the accuracy of amide proton transfer-weighted (APTw) MRI for identifying active glioma after treatment via radiographically guided... 
PSEUDOPROGRESSION | TRANSFER APT | DENTATE NUCLEUS | TUMOR PROGRESSION | ONCOLOGY | RESPONSE ASSESSMENT | RADIATION NECROSIS | CONTRAST | DIFFERENTIATION | HIGH-GRADE GLIOMAS | ENDOGENOUS PROTEIN
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 2018, Volume 14, Issue 3, pp. 468 - 474
Introduction: Nivolumab is effective in the treatment of previously treated patients with advanced NSCLC. However, its radiological evaluation is challenging... 
PD-L1 | Immune checkpoint inhibitor | Pseudoprogression | PD-1 | Nivolumab | ONCOLOGY | RESPIRATORY SYSTEM | RESPONSE EVALUATION CRITERIA | DOCETAXEL | PROGRESSION
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.